Leveraging Cell Painting Images to Expand the Applicability Domain and Actively Improve Deep Learning Quantitative Structure-Activity Relationship Models.
Journal
Chemical research in toxicology
ISSN: 1520-5010
Titre abrégé: Chem Res Toxicol
Pays: United States
ID NLM: 8807448
Informations de publication
Date de publication:
17 07 2023
17 07 2023
Historique:
medline:
18
7
2023
pubmed:
16
6
2023
entrez:
16
6
2023
Statut:
ppublish
Résumé
The search for chemical hit material is a lengthy and increasingly expensive drug discovery process. To improve it, ligand-based quantitative structure-activity relationship models have been broadly applied to optimize primary and secondary compound properties. Although these models can be deployed as early as the stage of molecule design, they have a limited applicability domain─if the structures of interest differ substantially from the chemical space on which the model was trained, a reliable prediction will not be possible. Image-informed ligand-based models partly solve this shortcoming by focusing on the phenotype of a cell caused by small molecules, rather than on their structure. While this enables chemical diversity expansion, it limits the application to compounds physically available and imaged. Here, we employ an active learning approach to capitalize on both of these methods' strengths and boost the model performance of a mitochondrial toxicity assay (Glu/Gal). Specifically, we used a phenotypic Cell Painting screen to build a chemistry-independent model and adopted the results as the main factor in selecting compounds for experimental testing. With the additional Glu/Gal annotation for selected compounds we were able to dramatically improve the chemistry-informed ligand-based model with respect to the increased recognition of compounds from a 10% broader chemical space.
Identifiants
pubmed: 37327474
doi: 10.1021/acs.chemrestox.2c00404
pmc: PMC10354798
doi:
Substances chimiques
Ligands
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1028-1036Références
SLAS Discov. 2023 Apr;28(3):111-117
pubmed: 36736829
PLoS One. 2013 Dec 02;8(12):e80999
pubmed: 24312513
Toxicol Sci. 1999 Mar;48(1):82-9
pubmed: 10330687
SLAS Discov. 2023 Apr;28(3):53-64
pubmed: 36639032
Chem Res Toxicol. 2020 Jan 21;33(1):223-238
pubmed: 31532188
Sci Rep. 2018 Jun 14;8(1):9110
pubmed: 29904147
Sci Rep. 2023 Mar 25;13(1):4908
pubmed: 36966203
J Med Chem. 1996 Jul 19;39(15):2887-93
pubmed: 8709122
Cell Chem Biol. 2018 May 17;25(5):611-618.e3
pubmed: 29503208
Expert Rev Mol Diagn. 2007 Mar;7(2):161-75
pubmed: 17331064
Drug Metab Pharmacokinet. 2011;26(1):3-14
pubmed: 20978361
Toxicol Sci. 2008 Jun;103(2):335-45
pubmed: 18344530
J Chem Inf Model. 2019 Mar 25;59(3):1163-1171
pubmed: 30840449
Nat Protoc. 2016 Sep;11(9):1757-74
pubmed: 27560178
Nat Commun. 2023 Apr 8;14(1):1967
pubmed: 37031208
Trends Pharmacol Sci. 2008 Jul;29(7):361-6
pubmed: 18501972
J Biomol Screen. 2012 Apr;17(4):496-506
pubmed: 22233649
Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1061-7
pubmed: 25023361
Annu Rev Pharmacol Toxicol. 2000;40:353-88
pubmed: 10836141
Nat Rev Drug Discov. 2021 Feb;20(2):145-159
pubmed: 33353986
Curr Protoc Toxicol. 2019 Jun;80(1):e76
pubmed: 31058461
Drug Discov Today. 2002 Jun 1;7(11):S83-8
pubmed: 12047885
Eur J Biochem. 2001 Apr;268(8):2512-9
pubmed: 11298771
ACS Chem Biol. 2022 Jul 15;17(7):1733-1744
pubmed: 35793809
Commun Biol. 2022 Aug 23;5(1):858
pubmed: 35999457
Front Artif Intell. 2021 Apr 14;4:638410
pubmed: 33937745
Curr Med Chem. 2005;12(16):1829-39
pubmed: 16101504
J Cheminform. 2023 Jun 2;15(1):56
pubmed: 37268960
Toxicol Appl Pharmacol. 2008 Dec 1;233(2):203-10
pubmed: 18817800
Toxicol In Vitro. 2013 Mar;27(2):560-9
pubmed: 23147640
Toxicol Sci. 2007 Jun;97(2):539-47
pubmed: 17361016
J Chem Inf Model. 2017 Jul 24;57(7):1591-1598
pubmed: 28628322
ACS Cent Sci. 2021 Aug 25;7(8):1356-1367
pubmed: 34471680